← Open Payments lookup

MAGGIE MACIAS: Open Payments

NPI 1972203404 · CORINTH, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$450 in 19 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $249 · 2025 $450

Food & beverage: $450
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP8$152
Bayer Healthcare Pharmaceuticals Inc.1$120
Lilly USA, LLC2$34
Novo Nordisk Inc2$33
Amgen Inc.2$31
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$30
GlaxoSmithKline, LLC.2$30
Esperion Therapeutics, Inc.1$20

Products named: Kerendia, FARXIGA, AIRSUPRA, JARDIANCE, CAPLYTA, TRELEGY ELLIPTA, NEXLETOL, OTEZLA.

Industry payments across MS — which companies pay providers there.